GSK shares have taken a hit in recent weeks due to Zantac uncertainty. Here, Edward Sheldon looks at whether they’re now cheap. The post Are GSK shares a bargain after falling 11%? appeared first on The Motley Fool UK.
GSK has launched an appeal against the Delaware Superior Court's recent so-called Daubert ruling.
This Fool is on the lookout for the best the stock market has to offer. He reckons these two could be solid candidates. The post I’m on the hunt for the best stocks on the market! I think I may have just found them appeared first on The Motley Fool UK.